
The plan emphasizes ensuring a stable supply of major medical isotopes. It aims to address supply gaps by researching and constructing internationally advanced research reactors and supporting experimental production facilities. This will enable differentiated production and stable supply of key medical isotopes such as molybdenum-99, carbon-14, strontium-89, yttrium-90, iodine-125, iodine-131, and lutetium-177, while breaking through technologies for developing and producing new medical isotopes. Molybdenum-99 (??Mo) is a radioactive isotope of molybdenum, with 42 protons, 57 neutrons, and a half-life of…